Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 48 entries
Sorted by: Best Match Show Resources per page
Microbial lipid and amino sugar responses to long-term simulated global environmental changes in a California annual grassland.

Frontiers in microbiology

Liang C, Gutknecht JL, Balser TC.
PMID: 25999926
Front Microbiol. 2015 May 05;6:385. doi: 10.3389/fmicb.2015.00385. eCollection 2015.

Global environmental change is predicted to have major consequences for carbon cycling and the functioning of soil ecosystems. However, we have limited knowledge about its impacts on the microorganisms, which act as a "valve" between carbon sequestered in soils...

Cite
Liang C, Gutknecht JL, Balser TC. Microbial lipid and amino sugar responses to long-term simulated global environmental changes in a California annual grassland. Front Microbiol. 2015;6:385doi: 10.3389/fmicb.2015.00385.
Liang, C., Gutknecht, J. L., & Balser, T. C. (2015). Microbial lipid and amino sugar responses to long-term simulated global environmental changes in a California annual grassland. Frontiers in microbiology, 6385. https://doi.org/10.3389/fmicb.2015.00385
Liang, Chao, et al. "Microbial lipid and amino sugar responses to long-term simulated global environmental changes in a California annual grassland." Frontiers in microbiology vol. 6 (2015): 385. doi: https://doi.org/10.3389/fmicb.2015.00385
Liang C, Gutknecht JL, Balser TC. Microbial lipid and amino sugar responses to long-term simulated global environmental changes in a California annual grassland. Front Microbiol. 2015 May 05;6:385. doi: 10.3389/fmicb.2015.00385. eCollection 2015. PMID: 25999926; PMCID: PMC4419726.
Copy Download .nbib Format: NLM
Evaluation of Effectiveness of Photodynamic Therapy With Low-level Diode Laser in Nonsurgical Treatment of Peri-implantitis.

Journal of lasers in medical sciences

Birang E, Talebi Ardekani MR, Rajabzadeh M, Sarmadi G, Birang R, Gutknecht N.
PMID: 29123634
J Lasers Med Sci. 2017;8(3):136-142. doi: 10.15171/jlms.2017.25. Epub 2017 Jun 27.

No abstract available.

Cite
Birang E, Talebi Ardekani MR, Rajabzadeh M, et al. Evaluation of Effectiveness of Photodynamic Therapy With Low-level Diode Laser in Nonsurgical Treatment of Peri-implantitis. J Lasers Med Sci. 2017;8(3):136-142doi: 10.15171/jlms.2017.25.
Birang, E., Talebi Ardekani, M. R., Rajabzadeh, M., Sarmadi, G., Birang, R., & Gutknecht, N. (2017). Evaluation of Effectiveness of Photodynamic Therapy With Low-level Diode Laser in Nonsurgical Treatment of Peri-implantitis. Journal of lasers in medical sciences, 8(3), 136-142. https://doi.org/10.15171/jlms.2017.25
Birang, Ehsan, et al. "Evaluation of Effectiveness of Photodynamic Therapy With Low-level Diode Laser in Nonsurgical Treatment of Peri-implantitis." Journal of lasers in medical sciences vol. 8,3 (2017): 136-142. doi: https://doi.org/10.15171/jlms.2017.25
Birang E, Talebi Ardekani MR, Rajabzadeh M, Sarmadi G, Birang R, Gutknecht N. Evaluation of Effectiveness of Photodynamic Therapy With Low-level Diode Laser in Nonsurgical Treatment of Peri-implantitis. J Lasers Med Sci. 2017;8(3):136-142. doi: 10.15171/jlms.2017.25. Epub 2017 Jun 27. PMID: 29123634; PMCID: PMC5662503.
Copy Download .nbib Format: NLM
Methods Used To Measure Patient Preferences In Psoriasis Treatments - An Overview With Regards To The German Iqwig And G-Ba.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Gutknecht M, Herrlein O, Augustin M.
PMID: 27201924
Value Health. 2014 Nov;17(7):A574. doi: 10.1016/j.jval.2014.08.1930. Epub 2014 Oct 26.

No abstract available.

Cite
Gutknecht M, Herrlein O, Augustin M. Methods Used To Measure Patient Preferences In Psoriasis Treatments - An Overview With Regards To The German Iqwig And G-Ba. Value Health. 2014;17(7):A574doi: 10.1016/j.jval.2014.08.1930.
Gutknecht, M., Herrlein, O., & Augustin, M. (2014). Methods Used To Measure Patient Preferences In Psoriasis Treatments - An Overview With Regards To The German Iqwig And G-Ba. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A574. https://doi.org/10.1016/j.jval.2014.08.1930
Gutknecht, M, et al. "Methods Used To Measure Patient Preferences In Psoriasis Treatments - An Overview With Regards To The German Iqwig And G-Ba." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A574. doi: https://doi.org/10.1016/j.jval.2014.08.1930
Gutknecht M, Herrlein O, Augustin M. Methods Used To Measure Patient Preferences In Psoriasis Treatments - An Overview With Regards To The German Iqwig And G-Ba. Value Health. 2014 Nov;17(7):A574. doi: 10.1016/j.jval.2014.08.1930. Epub 2014 Oct 26. PMID: 27201924.
Copy Download .nbib Format: NLM
ACP Journal Club. 13-year renal outcomes varied in patients with type 1 diabetes and new-onset microalbuminuria.

Annals of internal medicine

Gutknecht DR.
PMID: 21768579
Ann Intern Med. 2011 Jul 19;155(2):JC1-13. doi: 10.7326/0003-4819-155-2-201107190-02013.

No abstract available.

Cite
Gutknecht DR. ACP Journal Club. 13-year renal outcomes varied in patients with type 1 diabetes and new-onset microalbuminuria. Ann Intern Med. 2011;155(2):JC1-13doi: 10.7326/0003-4819-155-2-201107190-02013.
Gutknecht, D. R. (2011). ACP Journal Club. 13-year renal outcomes varied in patients with type 1 diabetes and new-onset microalbuminuria. Annals of internal medicine, 155(2), JC1-13. https://doi.org/10.7326/0003-4819-155-2-201107190-02013
Gutknecht, David R. "ACP Journal Club. 13-year renal outcomes varied in patients with type 1 diabetes and new-onset microalbuminuria." Annals of internal medicine vol. 155,2 (2011): JC1-13. doi: https://doi.org/10.7326/0003-4819-155-2-201107190-02013
Gutknecht DR. ACP Journal Club. 13-year renal outcomes varied in patients with type 1 diabetes and new-onset microalbuminuria. Ann Intern Med. 2011 Jul 19;155(2):JC1-13. doi: 10.7326/0003-4819-155-2-201107190-02013. PMID: 21768579.
Copy Download .nbib Format: NLM
Erratum to: The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells.

Cell communication and signaling : CCS

Gutknecht M, Geiger J, Joas S, Dörfel D, Salih HR, Müller MR, Grünebach F, Rittig SM.
PMID: 27188392
Cell Commun Signal. 2016 May 17;14(1):11. doi: 10.1186/s12964-016-0134-1.

No abstract available.

Cite
Gutknecht M, Geiger J, Joas S, et al. Erratum to: The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells. Cell Commun Signal. 2016;14(1):11doi: 10.1186/s12964-016-0134-1.
Gutknecht, M., Geiger, J., Joas, S., Dörfel, D., Salih, H. R., Müller, M. R., Grünebach, F., & Rittig, S. M. (2016). Erratum to: The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells. Cell communication and signaling : CCS, 14(1), 11. https://doi.org/10.1186/s12964-016-0134-1
Gutknecht, Michael, et al. "Erratum to: The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells." Cell communication and signaling : CCS vol. 14,1 (2016): 11. doi: https://doi.org/10.1186/s12964-016-0134-1
Gutknecht M, Geiger J, Joas S, Dörfel D, Salih HR, Müller MR, Grünebach F, Rittig SM. Erratum to: The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells. Cell Commun Signal. 2016 May 17;14(1):11. doi: 10.1186/s12964-016-0134-1. PMID: 27188392; PMCID: PMC4869397.
Copy Download .nbib Format: NLM
nanoString evaluation of murine Cytomegalovirus transcription in vivo and in vitro.

Journal of virological methods

Griessl M, Gutknecht M, Juranić-Lisnić V, Cook CH.
PMID: 34929204
J Virol Methods. 2021 Dec 17;301:114436. doi: 10.1016/j.jviromet.2021.114436. Epub 2021 Dec 17.

BACKGROUND: Next Generation Sequencing allows for deep analysis of transcriptional activity in cells and tissues, however it is still a cost intensive method that demands well versed data handling. Reverse transcription quantitative PCR (RT-qPCR) is the most commonly used...

Cite
Griessl M, Gutknecht M, Juranić-Lisnić V, et al. nanoString evaluation of murine Cytomegalovirus transcription in vivo and in vitro. J Virol Methods. 2021;301:114436doi: 10.1016/j.jviromet.2021.114436.
Griessl, M., Gutknecht, M., Juranić-Lisnić, V., & Cook, C. H. (2021). nanoString evaluation of murine Cytomegalovirus transcription in vivo and in vitro. Journal of virological methods, 301114436. https://doi.org/10.1016/j.jviromet.2021.114436
Griessl, Marion, et al. "nanoString evaluation of murine Cytomegalovirus transcription in vivo and in vitro." Journal of virological methods vol. 301 (2021): 114436. doi: https://doi.org/10.1016/j.jviromet.2021.114436
Griessl M, Gutknecht M, Juranić-Lisnić V, Cook CH. nanoString evaluation of murine Cytomegalovirus transcription in vivo and in vitro. J Virol Methods. 2021 Dec 17;301:114436. doi: 10.1016/j.jviromet.2021.114436. Epub 2021 Dec 17. PMID: 34929204.
Copy Download .nbib Format: NLM
Comparative Evaluation of the Effects of CO.

Journal of lasers in medical sciences

Naghsh N, Birang R, Shafiei F, Ghorbani F, Gutknecht N, Yaghini J.
PMID: 32099631
J Lasers Med Sci. 2020;11(1):74-80. doi: 10.15171/jlms.2020.13. Epub 2020 Jan 18.

No abstract available.

Cite
Naghsh N, Birang R, Shafiei F, et al. Comparative Evaluation of the Effects of CO. J Lasers Med Sci. 2020;11(1):74-80doi: 10.15171/jlms.2020.13.
Naghsh, N., Birang, R., Shafiei, F., Ghorbani, F., Gutknecht, N., & Yaghini, J. (2020). Comparative Evaluation of the Effects of CO. Journal of lasers in medical sciences, 11(1), 74-80. https://doi.org/10.15171/jlms.2020.13
Naghsh, Narges, et al. "Comparative Evaluation of the Effects of CO." Journal of lasers in medical sciences vol. 11,1 (2020): 74-80. doi: https://doi.org/10.15171/jlms.2020.13
Naghsh N, Birang R, Shafiei F, Ghorbani F, Gutknecht N, Yaghini J. Comparative Evaluation of the Effects of CO. J Lasers Med Sci. 2020;11(1):74-80. doi: 10.15171/jlms.2020.13. Epub 2020 Jan 18. PMID: 32099631; PMCID: PMC7008746.
Copy Download .nbib Format: NLM
Optimized Slurries for Spray Drying: Different Approaches to Obtain Homogeneous and Deformable Alumina-Zirconia Granules.

Materials (Basel, Switzerland)

Naglieri V, Gutknecht D, Garnier V, Palmero P, Chevalier J, Montanaro L.
PMID: 28788396
Materials (Basel). 2013 Nov 21;6(11):5382-5397. doi: 10.3390/ma6115382.

Spray drying is widely used for producing granulated feed materials for compaction process, which is the current industrial method for manufacturing alumina-zirconia femoral heads. The optimization of the granules compaction behavior requires the control of the slurry rheology. Moreover,...

Cite
Naglieri V, Gutknecht D, Garnier V, et al. Optimized Slurries for Spray Drying: Different Approaches to Obtain Homogeneous and Deformable Alumina-Zirconia Granules. Materials (Basel). 2013;6(11):5382-5397doi: 10.3390/ma6115382.
Naglieri, V., Gutknecht, D., Garnier, V., Palmero, P., Chevalier, J., & Montanaro, L. (2013). Optimized Slurries for Spray Drying: Different Approaches to Obtain Homogeneous and Deformable Alumina-Zirconia Granules. Materials (Basel, Switzerland), 6(11), 5382-5397. https://doi.org/10.3390/ma6115382
Naglieri, Valentina, et al. "Optimized Slurries for Spray Drying: Different Approaches to Obtain Homogeneous and Deformable Alumina-Zirconia Granules." Materials (Basel, Switzerland) vol. 6,11 (2013): 5382-5397. doi: https://doi.org/10.3390/ma6115382
Naglieri V, Gutknecht D, Garnier V, Palmero P, Chevalier J, Montanaro L. Optimized Slurries for Spray Drying: Different Approaches to Obtain Homogeneous and Deformable Alumina-Zirconia Granules. Materials (Basel). 2013 Nov 21;6(11):5382-5397. doi: 10.3390/ma6115382. PMID: 28788396; PMCID: PMC5452785.
Copy Download .nbib Format: NLM
Candesartan prevented development of diabetes mellitus in heart failure.

ACP journal club

Gutknecht DR.
PMID: 16388561
ACP J Club. 2006 Jan-Feb;144(1):11.

No abstract available.

Cite
Gutknecht DR. Candesartan prevented development of diabetes mellitus in heart failure. ACP J Club. 2006;144(1):11
Gutknecht, D. R. (2006). Candesartan prevented development of diabetes mellitus in heart failure. ACP journal club, 144(1), 11.
Gutknecht, David R. "Candesartan prevented development of diabetes mellitus in heart failure." ACP journal club vol. 144,1 (2006): 11.
Gutknecht DR. Candesartan prevented development of diabetes mellitus in heart failure. ACP J Club. 2006 Jan-Feb;144(1):11. PMID: 16388561.
Copy Download .nbib Format: NLM
Higher values of fasting plasma glucose within the normal range were associated with increased risk of type 2 diabetes.

Evidence-based medicine

Gutknecht DR.
PMID: 19043044
Evid Based Med. 2008 Dec;13(6):186. doi: 10.1136/ebm.13.6.186.

No abstract available.

Cite
Gutknecht DR. Higher values of fasting plasma glucose within the normal range were associated with increased risk of type 2 diabetes. Evid Based Med. 2008;13(6):186doi: 10.1136/ebm.13.6.186.
Gutknecht, D. R. (2008). Higher values of fasting plasma glucose within the normal range were associated with increased risk of type 2 diabetes. Evidence-based medicine, 13(6), 186. https://doi.org/10.1136/ebm.13.6.186
Gutknecht, David R. "Higher values of fasting plasma glucose within the normal range were associated with increased risk of type 2 diabetes." Evidence-based medicine vol. 13,6 (2008): 186. doi: https://doi.org/10.1136/ebm.13.6.186
Gutknecht DR. Higher values of fasting plasma glucose within the normal range were associated with increased risk of type 2 diabetes. Evid Based Med. 2008 Dec;13(6):186. doi: 10.1136/ebm.13.6.186. PMID: 19043044.
Copy Download .nbib Format: NLM
Comparative Effectiveness of An Acellular Synthetic Matrix As An Adjunct to Standard Care In The Treatment of Venous And Mixed Leg Ulcers: Modeling of Clinical Data And Routine Data.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Augustin M, Gutknecht M, Anastasiadou Z, Heyer K, Harding K, Shannon RJ, Heinrichs EL.
PMID: 27202091
Value Health. 2014 Nov;17(7):A604. doi: 10.1016/j.jval.2014.08.2100. Epub 2014 Oct 26.

No abstract available.

Cite
Augustin M, Gutknecht M, Anastasiadou Z, et al. Comparative Effectiveness of An Acellular Synthetic Matrix As An Adjunct to Standard Care In The Treatment of Venous And Mixed Leg Ulcers: Modeling of Clinical Data And Routine Data. Value Health. 2014;17(7):A604doi: 10.1016/j.jval.2014.08.2100.
Augustin, M., Gutknecht, M., Anastasiadou, Z., Heyer, K., Harding, K., Shannon, R. J., & Heinrichs, E. L. (2014). Comparative Effectiveness of An Acellular Synthetic Matrix As An Adjunct to Standard Care In The Treatment of Venous And Mixed Leg Ulcers: Modeling of Clinical Data And Routine Data. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A604. https://doi.org/10.1016/j.jval.2014.08.2100
Augustin, M, et al. "Comparative Effectiveness of An Acellular Synthetic Matrix As An Adjunct to Standard Care In The Treatment of Venous And Mixed Leg Ulcers: Modeling of Clinical Data And Routine Data." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A604. doi: https://doi.org/10.1016/j.jval.2014.08.2100
Augustin M, Gutknecht M, Anastasiadou Z, Heyer K, Harding K, Shannon RJ, Heinrichs EL. Comparative Effectiveness of An Acellular Synthetic Matrix As An Adjunct to Standard Care In The Treatment of Venous And Mixed Leg Ulcers: Modeling of Clinical Data And Routine Data. Value Health. 2014 Nov;17(7):A604. doi: 10.1016/j.jval.2014.08.2100. Epub 2014 Oct 26. PMID: 27202091.
Copy Download .nbib Format: NLM
FAIM Opposes Aggregation of Mutant SOD1 That Typifies Some Forms of Familial Amyotrophic Lateral Sclerosis.

Frontiers in neuroscience

Kaku H, Ludlow AV, Gutknecht MF, Rothstein TL.
PMID: 32153351
Front Neurosci. 2020 Feb 21;14:110. doi: 10.3389/fnins.2020.00110. eCollection 2020.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative illness that is unremittingly fatal and for which no effective treatment exists. All forms of ALS are characterized by protein aggregation. In familial forms of ALS, specific and heritable aggregation-prone proteins...

Cite
Kaku H, Ludlow AV, Gutknecht MF, et al. FAIM Opposes Aggregation of Mutant SOD1 That Typifies Some Forms of Familial Amyotrophic Lateral Sclerosis. Front Neurosci. 2020;14:110doi: 10.3389/fnins.2020.00110.
Kaku, H., Ludlow, A. V., Gutknecht, M. F., & Rothstein, T. L. (2020). FAIM Opposes Aggregation of Mutant SOD1 That Typifies Some Forms of Familial Amyotrophic Lateral Sclerosis. Frontiers in neuroscience, 14110. https://doi.org/10.3389/fnins.2020.00110
Kaku, Hiroaki, et al. "FAIM Opposes Aggregation of Mutant SOD1 That Typifies Some Forms of Familial Amyotrophic Lateral Sclerosis." Frontiers in neuroscience vol. 14 (2020): 110. doi: https://doi.org/10.3389/fnins.2020.00110
Kaku H, Ludlow AV, Gutknecht MF, Rothstein TL. FAIM Opposes Aggregation of Mutant SOD1 That Typifies Some Forms of Familial Amyotrophic Lateral Sclerosis. Front Neurosci. 2020 Feb 21;14:110. doi: 10.3389/fnins.2020.00110. eCollection 2020. PMID: 32153351; PMCID: PMC7047752.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 48 entries